SN
EDIT icon

Sittner & Nelson’s Editas Medicine EDIT Stock Holding History

Sittner & Nelson’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6
Closed -$45 – 459
2024
Q1 		$45 Buy
+6
New +$50 ﹤0.01% 493
2023
Q2 		– Sell
-300
Closed -$2.17K – 497
2023
Q1 		$2.17K Hold
300
– – ﹤0.01% 451
2022
Q4 		$2.66K Hold
300
– – ﹤0.01% 411
2022
Q3 		$4K Sell
300
-300
-50% -$4.67K ﹤0.01% 390
2022
Q2 		$7K Buy
600
+300
+100% +$4.02K ﹤0.01% 389
2022
Q1 		$6K Hold
300
– – ﹤0.01% 376
2021
Q4 		$8K Buy
+300
New +$10.3K ﹤0.01% 353

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sittner & Nelson's EDIT Position: Q2 2024 in Review

Sittner & Nelson sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 6 shares — an estimated $45 sold.

Sittner & Nelson first reported a position in EDIT in Q4 2021 and held it in 7 quarters. The position peaked at $8K in Q4 2021. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Sittner & Nelson reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Sittner & Nelson sold 6 Editas Medicine shares in Q2 2024, an estimated $45.
  • Sittner & Nelson first reported a position in Editas Medicine in Q4 2021 and held it in 7 quarters.
  • Sittner & Nelson's Editas Medicine position peaked at $8K in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Sittner & Nelson's 13F filing for Q2 2024, filed 13 Aug 2024.